Metronidazole is undergoing clinical trials in the treatment of anaerobic infections in the United States. In vitro studies suggest excellent activity against many clinical anaerobic pathogens (4) . Bacteroides fragilis is rapidly killed by metronidazole in vitro (11) . Clinical studies suggest that metronidazole is useful in serious anaerobic infections (7, 8, 10, (13) (14) (15) .
We report a potentially confusing factitious depression of the serum glutamic oxaloacetic transaminase (SGOT) (Table 1) . Onset of this abnormality was typically abrupt, although several patients had a gradual downward trend. With cessation of metronidazole the SGOT values returned promptly to pretreatment levels or to levels consistent with the patient's disease in all cases studied. An elevated SGOT prior to metronidazole therapy was not protective; six patients with an initially elevated SGOT were found to have abnormally low levels during therapy.
Other serum enzyme measurements, including lactic dehydrogenase and alkaline phosphatase, and bilirubin remained nornal or consistent with the patients' known diseases. One patient had multiple abdominal abscesses from an anastomatic breakdown after total gastrectomy. Prior to treatment his bilirubin, alkaline phosphatase, and SGOT were all elevated. During metronidazole therapy the SGOT decreased progressively, reaching a nadir of 0 IU. Twelve hours after cessation of metronidazole the SGOT rebounded to 264 IU, entirely compatible with his ilness.
SGOT levels are determined by a two-step enzymatic reaction. The unknown quantity of glutamic oxaloacetic transaminase (GOT) in serum catalyzes the reaction of alpha-ketoglutamic acid to oxaloacetic acid and glutamic acid. Oxaloacetic acid then reacts with reduced nicotinamide adenine dinucleotide (NADH) in the presence of malate dehydrogenase to form malate and NAD. NADH absorbs at 340 nm; NAD does not. The reaction is monitored at 340 nm; high levels of GOT are associated with decreased amounts of NADH and decreased absorbance at 340. Therefore, the SGOT scale is inverted such that low levels of SGOT are associated with high absorbency at 340 nm.
Metronidazole has an extinction coefficient of approximately 320 nm, but 65% of this activity remains at 340 nm (L. Hunt, personal communication). It was postulated that therapeutic levels of metronidazole interfered with the se-rum assay by nonspecific absorption, simulating that of NADH. Preliminary experiments disclosed that " spiking" normal human sera with metronidazole generated low SGOT readings. Five paired sera from patients receiving metronidazole were tested by Technicon's SMA-12/60 and SMAC systems. The SMAC system differs from the SMA-12/60 by using the patient's own sera as a blank. Absorbance is then compared to the blank. This system obviates nonspecific spectrophotometric absorption and more closely resembles a kinetic enzyme analysis. Comparison confirmed that the observed abnormality is artifactually induced by the method of measurement (Table 2 ).
Serum glutamic pyruvate transaminase results were also obtained in selected patients by using the SMAC system and were normal where studied; none were done on the SMA-12 system.
Factitious depression of absorption of NADH at 340 nm in the presence of metronidazole has been documented previously (5) . The effect was attenuated by using a 2-mm light path instead of the more conventional 10-mm light path. Both Technicon instruments use a rather long 15-mm light path, which would probably augment any nonspecific absorption.
Singh et al. studied the in vitro effect of 45 commonly used drugs on the 12 automated tests of the Technicon SMA 12/60 (12) . Only eight had effects at clinical concentrations. Most artifactual abnornalities of the SGOT are elevations, although depressions have been noted with psychotropics: fluspirilene (1), trifluoperazine (2), and clothiapine (9); and also with pindolol (9), progestogen (6), pyridoxine deficiency (3), and hemodialysis (16).
These factitious results should not be dismissed. One managing physician erroneously interpreted the cause of death as "total hepatic failure" in his patient because of these laboratory data. Several other physicians were confused and responded by ordering more SGOT determinations. Hepatic abscesses and peritoneal infections are commonly caused by anaerobic organisms, frequently by B. fragilis. Whereas diminution of parameters thought to assess obstructive biliary disease (bilirubin and alkaline phosphatase) are normally followed in these patients, the diminution of the SGOT is frequently used as ancillary evidence of inmprovement. Failure to appreciate the significance of these findings could allow the physician a false sense of security. LITERATURE CITED
